Paper20655352
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis.
Vener C and 11 others. Exp Hematol, 2010. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis. Papers, record 20655352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20655352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oxidative Stress | Major topic |
| Polycythemia Vera | Major topic |
| Primary Myelofibrosis | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Antioxidants | |
| Chronic Disease | |
| Female | |
| Folic Acid | |
| Homocysteine | |
| Humans | |
| Janus Kinase 2 | |
| Male | |
| Methylenetetrahydrofolate Reductase (NADPH2) | |
| Middle Aged | |
| Mutation | |
| Polymorphism, Single Nucleotide | |
| Reactive Oxygen Species | |
| Transcobalamins | |
| Vitamin B 12 |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42652218 | Malondialdehyde at the Crossroads of Oxidative Stress, Lipid Peroxidation, Ferroptosis, and Hematological Malignancies: A Narrative Review. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652218 | PubMed |
| 41003014 | Metabolomic Profiling Reveals Distinct Signatures in Primary and Secondary Polycythemia. | Metabolites | 2025 | https://conductscience.org/library/papers/41003014 | PubMed |
| 39917514 | Oxidant/Antioxidant Status in Patients with BCR-ABL1 Negative Myeloproliferative Neoplasms. | Indian J Hematol Blood Transfus | 2025 | https://conductscience.org/library/papers/39917514 | PubMed |
| 39337361 | The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337361 | PubMed |
| 39157201 | TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with Ph(-) Classical Myeloproliferative Neoplasm. | Mediators Inflamm | 2024 | https://conductscience.org/library/papers/39157201 | PubMed |
| 38928358 | Assessment of Total Antioxidant Capacity, 8-Hydroxy-2'-deoxy-guanosine, the Genetic Landscape, and Their Associations in BCR::ABL-1-Negative Chronic and Blast Phase Myeloproliferative Neoplasms. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928358 | PubMed |
| 37111286 | Bioactivity of Falkenbergia rufolanosa Methanolic Extract: Assessment of Its Effect on Methyl-Thiophanate Induced Bone and Blood Disorders. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37111286 | PubMed |
| 36831689 | Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36831689 | PubMed |
| 35818539 | Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2022 | https://conductscience.org/library/papers/35818539 | PubMed |
| 35628647 | PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628647 | PubMed |
| 35163413 | Neutrophil Death in Myeloproliferative Neoplasms: Shedding More Light on Neutrophils as a Pathogenic Link to Chronic Inflammation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163413 | PubMed |
| 35162937 | Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35162937 | PubMed |
| 35052617 | The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35052617 | PubMed |
| 34944059 | Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives. | Cells | 2021 | https://conductscience.org/library/papers/34944059 | PubMed |
| 33910797 | Acute liver failure after changing oral anticoagulant from apixaban to rivaroxaban. | BMJ Case Rep | 2021 | https://conductscience.org/library/papers/33910797 | PubMed |
| 33271863 | Protein Carbonylation and Lipid Peroxidation in Hematological Malignancies. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/33271863 | PubMed |
| 33114351 | Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33114351 | PubMed |
| 33114087 | Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR-ABL-Negative Myeloproliferative Neoplasm. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/33114087 | PubMed |
| 32962959 | Exploring redox vulnerabilities in JAK2V617F-positive cellular models. | Hematol Transfus Cell Ther | 2021 | https://conductscience.org/library/papers/32962959 | PubMed |
| 32045382 | Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32045382 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20655352
GET https://conductscience.org/api/papers/v1/20655352/cited_by?page=2